Healthcare -
Drug Manufacturers - Specialty & Generic - NASDAQ - US
$ 131.265
2.39 %
$ 14 B
Market Cap
-182.31
P/E
ITCI - OTHER CURRENT ASSETS
Other Current Assets ITCI - Intra-Cellular Therapies, Inc.
44.2 M
LAST VALUE
28.31%
2 YEAR CAGR
41.08%
5 YEAR CAGR
50.08%
10 YEAR CAGR